At a glance
- Originator Yakult Honsha
- Class Antihyperlipidaemics
- Mechanism of Action Sterol O-acyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hyperlipidaemia
Most Recent Events
- 09 Oct 2001 No-Development-Reported for Hyperlipidaemia in Japan (Unknown route)
- 05 Feb 1998 Preclinical development for Hyperlipidaemia in Japan (Unknown route)